Literature DB >> 28368975

EARLY DETECTION OF RETINAL HEMANGIOBLASTOMAS IN VON HIPPEL-LINDAU DISEASE USING ULTRA-WIDEFIELD FLUORESCEIN ANGIOGRAPHY.

Xuejing Chen1, Christian J Sanfilippo1, Aaron Nagiel1, Hamid Hosseini1, Devery Mitchell1, Colin A McCannel2, Steven D Schwartz1, Tara A McCannel1.   

Abstract

PURPOSE: To study the use of ultra-widefield fluorescein angiography (UWF FA) in the detection and management of retinal capillary hemangioblastomas in patients with von Hippel-Lindau disease.
METHODS: This is a retrospective study of patients with von Hippel-Lindau disease who underwent UWF FA using the Optos camera at a single center from June 2009 to May 2015. The clinical use of UWF FA was reviewed, and the number of hemangioblastomas identified on UWF FA was compared with ophthalmoscopy and a simulated seven standard field (7SF) FA montage.
RESULTS: Twenty eyes of 10 patients were identified. Only 33% of lesions seen on UWF FA were also found on ophthalmoscopy, and 88% of lesions visualized on UWF FA were located outside the 7SF overlay. In 5 eyes that had gaze steering, 18% of lesions could be visualized only on gaze-steered images. For the 14 eyes with data available, 6 had procedures recommended and 8 eyes observed based on data from UWF FA. One of 20 eyes had a lesion on ophthalmoscopy that was missed by imaging.
CONCLUSION: Ultra-widefield FA using the Optos camera is helpful for the evaluation and management of patients with von Hippel-Lindau disease. The UWF FA with gaze steering appears to detect more hemangioblastomas than ophthalmoscopy and conventional angiography.

Entities:  

Mesh:

Year:  2018        PMID: 28368975     DOI: 10.1097/IAE.0000000000001601

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  8 in total

1.  Expanded genetic carrier screening in clinical practice: a current survey of patient impressions and attitudes.

Authors:  Nigel Pereira; Michelle Wood; Emerly Luong; Allison Briggs; Michael Galloway; Rose A Maxwell; Steven R Lindheim
Journal:  J Assist Reprod Genet       Date:  2019-02-13       Impact factor: 3.412

Review 2.  MANAGEMENT OF RETINAL HEMANGIOBLASTOMA IN VON HIPPEL-LINDAU DISEASE.

Authors:  Henry E Wiley; Valerie Krivosic; Alain Gaudric; Michael B Gorin; Carol Shields; Jerry Shields; Mary E Aronow; Emily Y Chew
Journal:  Retina       Date:  2019-12       Impact factor: 4.256

Review 3.  Ultra-wide field retinal imaging: A wider clinical perspective.

Authors:  Vinod Kumar; Abhidnya Surve; Devesh Kumawat; Brijesh Takkar; Shorya Azad; Rohan Chawla; Daraius Shroff; Atul Arora; Ramandeep Singh; Pradeep Venkatesh
Journal:  Indian J Ophthalmol       Date:  2021-04       Impact factor: 1.848

4.  Evaluation of tumour surveillance protocols and outcomes in von Hippel-Lindau disease in a national health service.

Authors:  Eamonn R Maher; Julian Adlard; Julian Barwell; Angela F Brady; Paul Brennan; Jackie Cook; Gillian S Crawford; Tabib Dabir; Rosemarie Davidson; Rebecca Dyer; Rachel Harrison; Claire Forde; Dorothy Halliday; Helen Hanson; Eleanor Hay; Jenny Higgs; Mari Jones; Fiona Lalloo; Zosia Miedzybrodzka; Kai Ren Ong; Frauke Pelz; Deborah Ruddy; Katie Snape; James Whitworth; Richard N Sandford
Journal:  Br J Cancer       Date:  2022-02-19       Impact factor: 9.075

Review 5.  Ocular Manifestations of von Hippel-Lindau Disease.

Authors:  Misty D Ruppert; Meredith Gavin; Kelly T Mitchell; Alan N Peiris
Journal:  Cureus       Date:  2019-08-04

6.  Insights into retinal hemangioblastoma using ultra widefield imaging.

Authors:  Pradeep Kumar; Raghav Ravani; Sahil Agarwal; Suman Dhanda; Vinod Kumar
Journal:  Indian J Ophthalmol       Date:  2019-12       Impact factor: 1.848

Review 7.  Widefield imaging of retinal and choroidal tumors.

Authors:  Natalia F Callaway; Prithvi Mruthyunjaya
Journal:  Int J Retina Vitreous       Date:  2019-12-12

8.  Outcome and genetic analysis of patients affected by retinal capillary hemangioblastoma in von Hippel Lindau syndrome.

Authors:  Vittoria Murro; Myrta Lippera; Dario Pasquale Mucciolo; Letizia Canu; Tonino Ercolino; Giuseppina De Filpo; Dario Giorgio; Giovanna Traficante; Andrea Sodi; Gianni Virgili; Fabrizio Giansanti
Journal:  Mol Vis       Date:  2021-09-02       Impact factor: 2.367

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.